Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's disease

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Medication-overuse headache: a perspective review

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Pattern recognition receptor polymorphisms in early periodontitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lewis and AB0 blood group-phenotypes in periodontitis, cardiovascular disease, obesity and stroke

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gasotransmitters and the immune system: Mode of action and novel therapeutic targets

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events

    Research output: Contribution to journalReviewResearchpeer-review

  • Casper Steenholdt
  • Mark A Ainsworth
  • Michael Tovey
  • Tobias W Klausen
  • Ole O Thomsen
  • Jørn Brynskov
  • Klaus Bendtzen
View graph of relations
Several techniques are used to measure infliximab (IFX) and anti-IFX antibodies (Abs) in Crohn's disease. The aim of this study was to compare different assays for this purpose.
Original languageEnglish
JournalTherapeutic Drug Monitoring
Volume35
Issue number4
Pages (from-to)530-8
Number of pages9
ISSN0163-4356
DOIs
Publication statusPublished - Aug 2013

ID: 39736412